Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Encouraging preclinical data reported for glucosylceramide

March 26, 2004

Enrollment completed in phase II study of SPI-0211 for IBS

March 25, 2004

Phase I pharmacokinetic trial of orally dosed histamine completed

March 24, 2004

Protein Design Labs reports clinical data for visilizumab and fontolizumab

March 24, 2004

Axcan Pharma highlights recent developments

March 23, 2004

Safety and pharmacokinetics of the ribavirin prodrug viramidine in healthy volunteers

March 23, 2004

BMS team prepares and tests HCV NS5A inhibitors

March 23, 2004

Dosing under way in Genencor's phase I hepatitis B study

March 22, 2004

Long-term treatment of fistulizing Crohn's disease with infliximab

March 22, 2004

Interim results from phase II Alequel study

March 16, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.